跳至主要内容
临床试验/NCT03396380
NCT03396380Unknown3 期

Effect of Adding Vitamin D Supplement to Clomiphene Citrate for Induction of Ovulation in Overweight Women With Polycystic Ovary Syndrome

Ain Shams University1 个研究点 分布在 1 个国家目标入组 186 人开始时间: 2017年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
入组人数
186
试验地点
1
主要终点
Rate of ovulation

研究概览

简要总结

The aim of this work is to evaluate the effect of vitamin D supplementation in overweight infertile women with PCOs undergoing induction of ovulation.

详细描述

The study will include overweight infertile women with PCOS seeking fertility who will receive induction of ovulation by clomiphene citrate will be recruited and randomized into two groups:

Group A (study group): 93 women who will receive clomiphene citrate for induction of ovulation with vitamin D and calcium supplement

Group B (control group): 93 women who will receive clomiphene citrate for induction of ovulation with placebo and calcium supplement

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
25 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • polycystic ovarian syndrome diagnosis made according to ESHRE/ASRM criteria.
  • infertility is the cause for seeking treatment.
  • overweight females with BMI more than 25 but less than 30.

排除标准

  • causes of infertility other than PCOS.
  • causes of anovulation other than PCOS.
  • current or in last six months use of hormonal treatment.
  • contraindication to any drug used in the study.

研究组 & 干预措施

vitamin D

Active Comparator

93 women who will receive clomiphene citrate for induction of ovulation with vitamin D and calcium supplement

干预措施: Vitamin D with calcium and clomiphene citrate (Drug)

placebo

Placebo Comparator

93 women who will receive clomiphene citrate for induction of ovulation with placebo and calcium supplement

干预措施: Placebo Oral Tablet with calcium and clomiphene citrate (Drug)

结局指标

主要结局

Rate of ovulation

时间窗: till cycle day 21 if not reaching more than 18 mm

* Transvaginal ultrasound will be done to detect signs of ovulation: corpus luteum, fluid in cul-de-sac, collapse of the follicle size. * Serum progesterone will be measured in the mid luteal day of the cycle, where: Level 19 nmol/L indicates Ovulation. Level \<5 nmol/L suggests Ovulation did not occur

次要结局

  • Evaluation of the endometrial thickness(in cycle day 14 and 21.)
  • Adverse effects(for 3 months)
  • Number of growing follicles.(till cycle day 21 if not reaching more than 18 mm)
  • Pregnancy rates(pregnancy test 1 week after missed menses)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Radwa Rasheedy Ali

lecturer

Ain Shams University

研究点 (1)

Loading locations...

相似试验